Delivery Order SPE2DR25D2103-SPE2DR26F91WU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Concerta ER 18 mg tablets (100 count) valued at $18,688.60 under a firm fixed price contract. This delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a child...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Concerta ER (extended-release) 27 mg tablets. This competitively awarded, firm fixed-price delivery order has a ceiling value of approximately $24.9K and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a delivery order, this contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Concerta ER 18 mg tablets (100 count) with a contract value of $3,513.92. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025. The award was made through open competition with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a contract value of $6,339.04. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Concerta ER 18 mg tablets (100-count) with a ceiling value of $26,581.56. This firm fixed-price delivery order, which carries an ultimate completion date of August 11, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $6,691.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100 count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a task order issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed-price contract valued at $3,260.42, with an ultimate completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $15,296.82 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This award represents a child contract under the company's...
- The Defense Logistics Agency awarded a $2,551.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Concerta ER 18 mg tablets (100-count units). This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91WUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Concerta ER 18 mg tablets (100-count packages) valued at $15,452.62, with completion targeted for January 12, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contractor's extensive federal contract portfolio demonstrates consistent delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Concerta ER—a medication commonly used in treating attention deficit hyperactivity disorder—reflects the company's ongoing role as a critical vendor supporting military and federal healthcare operations through competitively awarded, non-set-aside contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 1/8/26 |